The Future of Oncology Summit – Hosted by BioCT & Yale Cancer Center

​See newly launched event microsite here.

The Future of Oncology Summit is the first-ever statewide event of its kind, co-hosted by the Yale Cancer Center and BioCT. This two-day convening brings together the leading voices in oncology from across the United States for forward-looking insights and high-impact collaboration defining the next era of cancer innovation. 

​The Summit focuses on three core areas:

• ​Science & Translation: Breakthroughs in tumor biology, precision medicine, and clinical translation across major cancer subtypes
• Tech Platforms, AI, and Data Science: How machine learning and data platforms are transforming discovery, diagnostics, and care
• ​BD & Venture: Insights on incentives for funding from various transactions that monetize value from industry leaders and investors

An exceptional lineup of world-renowned speakers—including Annie Lamont, Managing Partner, Oak HC/FT, and Clifford Hudis, CEO, ASCO—will participate alongside the scientific pioneers and top executives shaping the future of oncology. See the full list of esteemed panelists here.

Thank you to our generous sponsors:

Presenting Sponsors: AstraZeneca

Reception Sponsors: Access Biotechnology, Canaan, Deep Track Capital, Frazier Life Sciences, RA Capital, Vida Ventures

Gold Sponsor: Novartis

Premier Sponsors:  AbbVie, Johnson & Johnson

Lunch Sponsors: Citizens Private Bank, Wiggin and Dana

Breakfast Sponsor: CFGI

Table Sponsors: Arvinas, Biolabs New Haven, CellsBin, Guardant, Medtronic, Precision Biotools, Revolution Medicines, Syndax, Yale Ventures

Supporter Sponsors: Connecticut Innovations, Deloitte, EvolveImmune Therapeutics, Greater New Haven Chamber of Commerce, Normunity, Parabilis Medicines, Pfizer, Winstanley Enterprises, WIB-Connecticut

Illustration Sponsor: XVIVO Scientific Animation

For details on sponsorship opportunities, please click here.